130 related articles for article (PubMed ID: 29132464)
1. [Clinical manifestations and genetic diagnosis of paroxysmal kinesigenic dyskinesia].
Zhu XM; Gong YH; Lu S; Cheng SC; Yao BZ
Zhongguo Dang Dai Er Ke Za Zhi; 2017 Nov; 19(11):1169-1173. PubMed ID: 29132464
[TBL] [Abstract][Full Text] [Related]
2. [Clinical features and PRRT2 gene mutation in paroxysmal kinesigenic dyskinesia].
Yang X; Zhang Y; Xu X; Yang Z; Wang S; Wu Y; Wu X
Zhonghua Er Ke Za Zhi; 2015 Aug; 53(8):621-5. PubMed ID: 26717662
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and PRRT2 gene mutation analysis of sporadic patients with paroxysmal kinesigenic dyskinesia in China.
Zhang Y; Li L; Chen W; Gan J; Liu ZG
Clin Neurol Neurosurg; 2017 Aug; 159():25-28. PubMed ID: 28525812
[TBL] [Abstract][Full Text] [Related]
4. 16p11.2 deletion in patients with paroxysmal kinesigenic dyskinesia but without intellectual disability.
Li W; Wang Y; Li B; Tang B; Sun H; Lai J; He N; Li B; Meng H; Liao W; Liu X
Brain Behav; 2018 Nov; 8(11):e01134. PubMed ID: 30307717
[TBL] [Abstract][Full Text] [Related]
5. Clinical and genetic analyses of 150 patients with paroxysmal kinesigenic dyskinesia.
Liu X; Ke H; Qian X; Wang S; Zhan F; Li Z; Tian W; Huang X; Zhang B; Cao L
J Neurol; 2022 Sep; 269(9):4717-4728. PubMed ID: 35428900
[TBL] [Abstract][Full Text] [Related]
6. Paroxysmal kinesigenic dyskinesia: Clinical and genetic analyses of 110 patients.
Huang XJ; Wang T; Wang JL; Liu XL; Che XQ; Li J; Mao X; Zhang M; Bi GH; Wu L; Zhang Y; Wang JY; Shen JY; Tang BS; Cao L; Chen SD
Neurology; 2015 Nov; 85(18):1546-53. PubMed ID: 26446061
[TBL] [Abstract][Full Text] [Related]
7. A new genetic diagnosis strategy for paroxysmal kinesigenic dyskinesia: Targeted high-throughput detection of PRRT2 gene c.649 locus.
Wen M; Huang H; Huang F; Xu R; Zhang J; Fan JG; Zeng J; Jiang KW; Liu D; Huang HL; He QN
Mol Genet Genomic Med; 2024 May; 12(5):e2469. PubMed ID: 38778723
[TBL] [Abstract][Full Text] [Related]
8. Paroxysmal Kinesigenic Dyskinesia.
Paucar M; Malmgren H; Svenningsson P
Tremor Other Hyperkinet Mov (N Y); 2017; 7():529. PubMed ID: 29276650
[TBL] [Abstract][Full Text] [Related]
9. Clinical features of patients with paroxysmal kinesigenic dyskinesia, mutation screening of PRRT2 and the effects of morning draughts of oxcarbazepine.
Pan G; Zhang L; Zhou S
BMC Pediatr; 2019 Nov; 19(1):439. PubMed ID: 31722684
[TBL] [Abstract][Full Text] [Related]
10. PRRT2 mutations in a cohort of Chinese families with paroxysmal kinesigenic dyskinesia and genotype-phenotype correlation reanalysis in literatures.
Zhao G; Liu X; Zhang Q; Wang K
Int J Neurosci; 2018 Aug; 128(8):751-760. PubMed ID: 29285950
[TBL] [Abstract][Full Text] [Related]
11. Paroxysmal Kinesigenic Dyskinesia: First Molecularly Confirmed Case from Africa.
Dekker MCJ; Chengo R; Kumburu HH; Kamsteeg EJ; Hamel BC
Tremor Other Hyperkinet Mov (N Y); 2019; 10():. PubMed ID: 32002278
[TBL] [Abstract][Full Text] [Related]
12. Lacosamide for children with paroxysmal kinesigenic dyskinesia.
Furukawa G; Negishi Y; Takeuchi T; Ishihara N; Okumura A
Brain Dev; 2020 Sep; 42(8):617-620. PubMed ID: 32430160
[TBL] [Abstract][Full Text] [Related]
13. PRRT2 phenotypes and penetrance of paroxysmal kinesigenic dyskinesia and infantile convulsions.
van Vliet R; Breedveld G; de Rijk-van Andel J; Brilstra E; Verbeek N; Verschuuren-Bemelmans C; Boon M; Samijn J; Diderich K; van de Laar I; Oostra B; Bonifati V; Maat-Kievit A
Neurology; 2012 Aug; 79(8):777-84. PubMed ID: 22875091
[TBL] [Abstract][Full Text] [Related]
14. Mutation Analysis of MR-1, SLC2A1, and CLCN1 in 28 PRRT2-negative Paroxysmal Kinesigenic Dyskinesia Patients.
Wang HX; Li HF; Liu GL; Wen XD; Wu ZY
Chin Med J (Engl); 2016 May; 129(9):1017-21. PubMed ID: 27098784
[TBL] [Abstract][Full Text] [Related]
15. Clinical and genetic features of paroxysmal kinesigenic dyskinesia in Italian patients.
Lamperti C; Invernizzi F; Solazzi R; Freri E; Carella F; Zeviani M; Zibordi F; Fusco C; Zorzi G; Granata T; Garavaglia B; Nardocci N
Eur J Paediatr Neurol; 2016 Jan; 20(1):152-7. PubMed ID: 26384010
[TBL] [Abstract][Full Text] [Related]
16. Analysis of catechol-O-methyltransferase gene mutation and identification of new pathogenic gene for paroxysmal kinesigenic dyskinesia.
Gu C; Li J; Zhu L; Lu Z; Huang H
Neurol Sci; 2016 Mar; 37(3):377-83. PubMed ID: 26650803
[TBL] [Abstract][Full Text] [Related]
17. PRRT2 mutations in Japanese patients with benign infantile epilepsy and paroxysmal kinesigenic dyskinesia.
Okumura A; Shimojima K; Kurahashi H; Numoto S; Shimada S; Ishii A; Ohmori I; Takahashi S; Awaya T; Kubota T; Sakakibara T; Ishihara N; Hattori A; Torisu H; Tohyama J; Inoue T; Haibara A; Nishida T; Yuhara Y; Miya K; Tanaka R; Hirose S; Yamamoto T
Seizure; 2019 Oct; 71():1-5. PubMed ID: 31154286
[TBL] [Abstract][Full Text] [Related]
18. PRRT2 Mutation and Serum Cytokines in Paroxysmal Kinesigenic Dyskinesia.
Xu K; Huang SS; Yue DY; Li G; Zhu SQ; Liu XY
Curr Med Sci; 2022 Apr; 42(2):280-285. PubMed ID: 35438471
[TBL] [Abstract][Full Text] [Related]
19. Benign infantile convulsions (IC) and subsequent paroxysmal kinesigenic dyskinesia (PKD) in a patient with 16p11.2 microdeletion syndrome.
Weber A; Köhler A; Hahn A; Neubauer B; Müller U
Neurogenetics; 2013 Nov; 14(3-4):251-3. PubMed ID: 24100940
[TBL] [Abstract][Full Text] [Related]
20. TMEM151A as an alternative to PRRT2 in paroxysmal kinesigenic dyskinesia: About three new cases.
Mounir Alaoui O; Charbonneau PF; Prin P; Mongin M; Choquer M; Damier P; Riant F; Degos B
Parkinsonism Relat Disord; 2023 Mar; 108():105295. PubMed ID: 36724570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]